You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

trastuzumab

Showing 26 - 50 of 1,505
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy Trial (SHR-A1811,

Not yet recruiting
  • HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy
  • (no location specified)
Nov 7, 2023

Metastatic Breast Cancer, Metastatic Gastric Cancer Trial in Changchun (Trastuzumab for injection, Herceptin)

Completed
  • Metastatic Breast Cancer
  • Metastatic Gastric Cancer
  • Changchun, Jilin, China
    Affiliated Hospital of Changchun University of Traditional Chine
Mar 1, 2023

Breast Cancer Trial in Shenyang (Pyrotinib, Trastuzumab, Dalpiciclib)

Not yet recruiting
  • Breast Cancer
  • Shenyang, Liaoning, China
    Shengjing Hospital of China Medical University
Dec 2, 2022

Breast Cancer Trial in Sweden (Trastuzumab deruxtecan, Docetaxel, Paclitaxel)

Not yet recruiting
  • Breast Cancer
  • Trastuzumab deruxtecan
  • +9 more
  • Malmö, Sweden
  • +6 more
Jun 8, 2023

HER2-positive Breast Cancer Trial in Nanjing (HS022, Trastuzumab, Vinorelbine Bitartrate)

Completed
  • HER2-positive Breast Cancer
  • Nanjing, Jiangsu, China
    Jiangsu Province People's Hospital (First Affiliated Hospital of
Oct 25, 2023

Breast Cancer, Metastatic Breast Cancer, HER2-positive Breast Cancer Trial in Amsterdam (89Zr-DFO*-trastuzumab PET scan)

Recruiting
  • Breast Cancer
  • +5 more
  • 89Zr-DFO*-trastuzumab PET scan
  • Amsterdam, Noord-Holland, Netherlands
    AmsterdamUMC
Jul 12, 2023

Breast Cancer, Tumor Metastasis Trial in Houston (Trastuzumab, RAD001)

Completed
Has Results
  • Breast Cancer
  • Neoplasm Metastasis
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 30, 2022

Pyrotinib Plus Trastuzumab and Chemotherapy in HER2+ Metastatic

Completed
  • Breast Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Apr 20, 2023

    Trastuzumab Emtansine as Therapy in Chinese HER2 Positive

    Not yet recruiting
    • Breast Cancer
    • Trastuzumab emtansine
    • (no location specified)
    Jul 13, 2023

    Breast Tumors, Malignant Tumor of the Breast Trial in Multiple Locations (Trastuzumab, Pertuzumab, Vinorelbine, Paclitaxel,

    Terminated
    • Breast Neoplasms
    • Malignant Tumor of the Breast
    • Trastuzumab
    • +2 more
    • Multiple Locations, Texas
      19 Sites
    Nov 29, 2022

    HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer Trial in Seoul

    Not yet recruiting
    • HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer
    • Seoul, Korea, Republic of
      Severance Hospital, Yonsei University Health System
    Feb 19, 2023

    HER2-positive Advanced Gastric Cancer Trial (trastuzumab, bevacizumab with paclitaxel (triple combination))

    Not yet recruiting
    • HER2-positive Advanced Gastric Cancer
    • trastuzumab, bevacizumab with paclitaxel (triple combination)
    • (no location specified)
    Dec 6, 2022

    Breast Tumor Female Trial (Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy)

    Not yet recruiting
    • Breast Neoplasm Female
    • Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy
    • (no location specified)
    Oct 17, 2022

    HER2+ Advanced Breast Cancer, Other Solid Tumors Trial (ADCC-R-Epo-R T-cells + Trastuzumab, Erythropoietin beta, Fludarabine and

    Not yet recruiting
    • HER2+ Advanced Breast Cancer
    • Other Solid Tumors
    • ADCC-R-Epo-R T-cells + Trastuzumab
    • +2 more
    • (no location specified)
    Aug 31, 2023

    HER2-positive Early Breast Cancer Trial in Germany (Trastuzumab deruxtecan, Standard-of-Care)

    Not yet recruiting
    • HER2-positive Early Breast Cancer
    • Munich, Bavaria, Germany
    • +11 more
    Jan 19, 2023

    Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Scottsdale, Jacksonville, Rochester

    Not yet recruiting
    • Castration-Resistant Prostate Carcinoma
    • Stage IVB Prostate Cancer AJCC v8
    • Biopsy
    • +7 more
    • Scottsdale, Arizona
    • +2 more
    Feb 15, 2023

    Metastatic Solid Tumor, Brain Metastases Trial in Houston (Trastuzumab emtansine, Tucatinib)

    Not yet recruiting
    • Metastatic Solid Tumor
    • Brain Metastases
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 30, 2022

    HER2-positive Breast Cancer Trial in Amsterdam (Trastuzumab deruxtecan)

    Not yet recruiting
    • HER2-positive Breast Cancer
    • Trastuzumab deruxtecan
    • Amsterdam, Netherlands
      Antoni van Leeuwenhoek
    Aug 7, 2023

    Breast Cancer Trial in Taizhou (Pyrotinib)

    Recruiting
    • Breast Cancer
    • Taizhou, Zhejiang, China
      Taizhou Hospital
    May 26, 2023

    Anatomic Stage IV Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States

    Recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +2 more
    • Los Angeles, California
    • +4 more
    Jul 19, 2022

    Metastatic HER2-Positive Breast Cancer Trial in United States (Gemcitabine, Trastuzumab, Pertuzumab)

    Active, not recruiting
    • Metastatic HER2-Positive Breast Cancer
    • Hartford, Connecticut
    • +4 more
    Dec 1, 2022

    HER2-positive Breast Cancer, Leptomeningeal Metastasis, Leptomeningeal Disease Trial in Tampa, Evanston (Radiation Therapy,

    Recruiting
    • HER2-positive Breast Cancer
    • +2 more
    • Radiation Therapy
    • +2 more
    • Tampa, Florida
    • +1 more
    Dec 30, 2022

    Breast Cancer, Metastatic Breast Cancer Trial (Trastuzumab-Deruxtecan (T-DXd))

    Not yet recruiting
    • Breast Cancer
    • Metastatic Breast Cancer
    • Trastuzumab-Deruxtecan (T-DXd)
    • (no location specified)
    Sep 20, 2023

    HER2-positive Breast Cancer Trial in China (TQB2440 injection + Trastuzumab + Docetaxel, Perjeta + Trastuzumab + Docetaxel)

    Active, not recruiting
    • HER2-positive Breast Cancer
    • TQB2440 injection + Trastuzumab + Docetaxel
    • Perjeta + Trastuzumab + Docetaxel
    • Chongqing, Chongqing, China
    • +5 more
    Aug 3, 2023

    Breast Cancer Trial in Shanghai (Dalpiciclib, Fulvestrant, Pertuzumab)

    Active, not recruiting
    • Breast Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Oct 10, 2022